•
Hong Kong-based WinHealth Pharma Group Ltd has announced a strategic partnership with Nippon Shinyaku Co Ltd’s wholly owned subsidiary in Tianjin, China, focusing on the promotion of Gaslon N (irsogladine). While specific financial details of the collaboration remain undisclosed, this partnership marks a significant step for both companies in the…